Catalyst Wire Dossier Catalyst Wire Dossier

INNO-406

nilotinib · CytRx
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INNO-406, covering 2009-06-01 to 2009-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia [Phase 1]

See pricing